Lab Insights - How to implement HPV DNA testing as a primary screening tool?

How to implement HPV DNA testing as a primary screening tool?

June 28, 2019

Article

Webinars Cervical Cancer Molecular Diagnostics Oncology Women's Health

แชร์สิ่งนี้:

HPV DNA testing is shown to be significantly more effective compared to pap smear/cytology for cervical cancer screening. In this webinar, you will learn how to implement HPV DNA testing as a primary screening tool for cervical cancer.

How to address multidisciplinary challenges during the transition phase from pap smear/cytology to HPV DNA testing?
What are the considerations when choosing a reliable and clinically relevant HPV DNA test?
What are some practical tips in supporting implementation of HPV DNA testing as a primary screening tool in your country?

แชร์สิ่งนี้:

เพิ่มเติมในหัวข้อเดียวกัน

Pap in the City: a journey to co-testing for HPV in Hong Kong

A.Cheng

Time to review the gold standard for cervical cancer screening

W.Termrungruanglert

หัวข้อแนะนำ

ดูหัวข้อเพิ่มเติม

สิ่งที่ต้องอ่านถัดไป

C-Suite Perspectives, Event Coverage, Healthcare Transformation, Management, RED 2024

Dr William Morice II’s visions and considerations for building a global diagnostics ecosystem

W.Morice II

C-Suite Perspectives, Leaders In Conversation, Management

Awanui Group’s quest to improve lab diagnostics in New Zealand: Q&A with Anoop Singh (Part 1)

A.Singh, W.Wong

Healthcare Transformation, Management, Operations, Population Health Management

‘Real world evidence’ and clinical labs: a brief introduction

C.Hardesty

Disease Area, Healthcare Transformation, Histopathology, Leaders In Conversation, Management, Oncology, Operations

‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)

T.Grogan